Here, we investigated the effect of 1-kestose supplementation on glucose metabolism, i.e., fasting insulin level and glucose intolerance, in HFD-fed rats as a preliminary study, and then conducted a clinical trial to examine the feasibility of 1-kestose to improve insulin resistance in obesity-prone participants. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.